+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Biotechnology & Pharmaceutical Services Outsourcing Market by Service Type, Therapeutic Area, End User, Outsourcing Model - Global Forecast to 2030- Product Image
Biotechnology & Pharmaceutical Services Outsourcing Market by Service Type, Therapeutic Area, End User, Outsourcing Model - Global Forecast to 2030- Product Image
Sale

Biotechnology & Pharmaceutical Services Outsourcing Market by Service Type, Therapeutic Area, End User, Outsourcing Model - Global Forecast to 2030

  • PDF Icon

    Report

  • 196 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 6010907
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Outsourcing in the biotechnology and pharmaceutical services sector is rapidly transforming operational strategies, enabling organizations to access advanced expertise, accelerate project timelines, and mitigate risk amid evolving regulatory and economic conditions. For senior decision-makers, understanding the contours of this market is crucial to steering growth and optimizing value.

Market Snapshot: Biotechnology & Pharmaceutical Services Outsourcing Market

The Biotechnology & Pharmaceutical Services Outsourcing Market grew from USD 167.95 billion in 2024 to USD 188.18 billion in 2025. It is expected to continue growing at a CAGR of 11.94%, reaching USD 330.57 billion by 2030.

Scope & Segmentation

  • Service Type: Clinical research (across all trial phases), contract manufacturing (active pharmaceutical ingredient, biologics, fill-finish, formulation development), laboratory services (analytical testing, genomics proteomics, microbiology, stability testing), pharmacovigilance (adverse event reporting, risk management, signal detection), preclinical research (bioanalytical, in vitro, in vivo, toxicology studies), and regulatory affairs (dossier preparation, labeling, consulting).
  • Therapeutic Area: Cardiovascular, infectious disease, neurology, oncology.
  • End User: Biotech companies, contract research organizations, medical device companies, pharmaceutical companies, research institutes.
  • Outsourcing Model: Full service outsourcing, functional service provider, project-based outsourcing, staff augmentation.
  • Geographies: Americas (United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (including United Kingdom, Germany, France, Italy, Spain, and selected Middle East and African countries), and Asia-Pacific (China, India, Japan, Australia, South Korea, Southeast Asia, and others).
  • Key Players: Companies profiled include IQVIA Holdings Inc., Laboratory Corporation of America Holdings, Thermo Fisher Scientific Inc., Syneos Health, Parexel International, ICON plc, Charles River Laboratories, WuXi AppTec, Catalent, and Medpace Holdings.

Key Takeaways for Decision-Makers

  • Strategic outsourcing alliances drive innovation by enabling access to specialized laboratory services, operational efficiency, and optimized resource allocation across research, manufacturing, and regulatory processes.
  • Integration of digital platforms, including artificial intelligence and machine learning, is increasingly critical for accelerating data interpretation and supporting advanced clinical and preclinical research functions.
  • Geographical diversification allows organizations to reduce delays, enhance patient recruitment, and navigate the growing complexity of region-specific regulatory requirements.
  • Blurring of boundaries among contract research, manufacturing, and laboratory services is fostering integrated end-to-end outsourcing models, allowing for streamlined vendor management and minimized inefficiencies.
  • Oncology remains a primary driver of service demand, with increased program activity also evident in infectious disease, neurology, and cardiovascular research due to shifting public health priorities and unmet clinical needs.

Tariff Impact: Navigating New Cost Pressures

The introduction of updated U.S. tariff structures for 2025 adds complexity across the outsourcing value chain. Increased import duties on critical raw materials and laboratory equipment are elevating input costs and prompting organizations to reexamine their sourcing and supply strategies. Many are responding by exploring nearshoring options within the Americas, adjusting logistics, and renegotiating long-term contracts to maintain margin predictability and safeguard operational resilience. Service providers must adopt more granular cost models and risk management approaches to adapt to this evolving regulatory landscape.

Methodology & Data Sources

This analysis is based on a comprehensive research framework that includes in-depth interviews with senior executives and functional leaders across global biotechnology and pharmaceutical organizations. Primary research is supported by rigorous secondary analysis of regulatory filings, industry publications, and validated datasets. Data triangulation and peer review ensure accuracy and objectivity in the assessment of market trends and segmentation.

Why This Report Matters

  • Gain actionable clarity to inform strategic outsourcing and vendor selection decisions amid changing technology, regulatory, and tariff environments.
  • Benchmark service delivery models, segment growth opportunities, and competitive positioning to build more agile, resilient operational strategies.
  • Mitigate compliance, cost, and supply chain risks while capitalizing on emerging global trends in biotechnology and pharmaceutical services outsourcing.

Conclusion

As biotechnology and pharmaceutical service outsourcing evolves, decision-makers must navigate shifting regulatory, economic, and technological landscapes. This report offers the insight needed to align strategy, ensure compliance, and sharpen competitive positioning for sustained growth.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Biotechnology & Pharmaceutical Services Outsourcing Market, by Service Type
8.1. Introduction
8.2. Clinical Research
8.2.1. Phase I
8.2.2. Phase Ii
8.2.3. Phase Iii
8.2.4. Phase Iv
8.3. Contract Manufacturing
8.3.1. Active Pharmaceutical Ingredient Manufacturing
8.3.2. Biologics Manufacturing
8.3.3. Fill-Finish Services
8.3.4. Formulation Development
8.4. Laboratory Services
8.4.1. Analytical Testing
8.4.2. Genomics Proteomics
8.4.3. Microbiology Testing
8.4.4. Stability Testing
8.5. Pharmacovigilance
8.5.1. Adverse Event Reporting
8.5.2. Risk Management
8.5.3. Signal Detection
8.6. Preclinical Research
8.6.1. Bioanalytical Services
8.6.2. In Vitro Testing
8.6.3. In Vivo Testing
8.6.4. Toxicology Studies
8.7. Regulatory Affairs
8.7.1. Dossier Preparation
8.7.2. Labeling Services
8.7.3. Regulatory Consulting
9. Biotechnology & Pharmaceutical Services Outsourcing Market, by Therapeutic Area
9.1. Introduction
9.2. Cardiovascular
9.3. Infectious Disease
9.4. Neurology
9.5. Oncology
10. Biotechnology & Pharmaceutical Services Outsourcing Market, by End User
10.1. Introduction
10.2. Biotech Companies
10.3. Cros
10.4. Medical Device Companies
10.5. Pharmaceutical Companies
10.6. Research Institutes
11. Biotechnology & Pharmaceutical Services Outsourcing Market, by Outsourcing Model
11.1. Introduction
11.2. Full Service Outsourcing
11.3. Functional Service Provider
11.4. Project-Based Outsourcing
11.5. Staff Augmentation
12. Americas Biotechnology & Pharmaceutical Services Outsourcing Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Biotechnology & Pharmaceutical Services Outsourcing Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Biotechnology & Pharmaceutical Services Outsourcing Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. IQVIA Holdings Inc.
15.3.2. Laboratory Corporation of America Holdings
15.3.3. Thermo Fisher Scientific Inc.
15.3.4. Syneos Health, Inc.
15.3.5. Parexel International Corporation
15.3.6. ICON plc
15.3.7. Charles River Laboratories International, Inc.
15.3.8. WuXi AppTec Co., Ltd.
15.3.9. Catalent, Inc.
15.3.10. Medpace Holdings, Inc.
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET MULTI-CURRENCY
FIGURE 2. BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET MULTI-LANGUAGE
FIGURE 3. BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY THERAPEUTIC AREA, 2024 VS 2030 (%)
FIGURE 10. GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY THERAPEUTIC AREA, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY OUTSOURCING MODEL, 2024 VS 2030 (%)
FIGURE 14. GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY OUTSOURCING MODEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY CLINICAL RESEARCH, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY PHASE I, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY PHASE II, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY PHASE III, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY PHASE IV, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY CLINICAL RESEARCH, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY CONTRACT MANUFACTURING, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY ACTIVE PHARMACEUTICAL INGREDIENT MANUFACTURING, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY BIOLOGICS MANUFACTURING, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY FILL-FINISH SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY FORMULATION DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY CONTRACT MANUFACTURING, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY LABORATORY SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY ANALYTICAL TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY GENOMICS PROTEOMICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY MICROBIOLOGY TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY STABILITY TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY LABORATORY SERVICES, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY PHARMACOVIGILANCE, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY ADVERSE EVENT REPORTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY RISK MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SIGNAL DETECTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY PHARMACOVIGILANCE, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY PRECLINICAL RESEARCH, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY BIOANALYTICAL SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY IN VITRO TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY IN VIVO TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY TOXICOLOGY STUDIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY PRECLINICAL RESEARCH, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY REGULATORY AFFAIRS, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY DOSSIER PREPARATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY LABELING SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY REGULATORY CONSULTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY REGULATORY AFFAIRS, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY INFECTIOUS DISEASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY BIOTECH COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY CROS, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY MEDICAL DEVICE COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY OUTSOURCING MODEL, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY FULL SERVICE OUTSOURCING, BY REGION, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY FUNCTIONAL SERVICE PROVIDER, BY REGION, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY PROJECT-BASED OUTSOURCING, BY REGION, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY STAFF AUGMENTATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 57. AMERICAS BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 58. AMERICAS BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY CLINICAL RESEARCH, 2018-2030 (USD MILLION)
TABLE 59. AMERICAS BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY CONTRACT MANUFACTURING, 2018-2030 (USD MILLION)
TABLE 60. AMERICAS BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY LABORATORY SERVICES, 2018-2030 (USD MILLION)
TABLE 61. AMERICAS BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY PHARMACOVIGILANCE, 2018-2030 (USD MILLION)
TABLE 62. AMERICAS BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY PRECLINICAL RESEARCH, 2018-2030 (USD MILLION)
TABLE 63. AMERICAS BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY REGULATORY AFFAIRS, 2018-2030 (USD MILLION)
TABLE 64. AMERICAS BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 65. AMERICAS BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 66. AMERICAS BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY OUTSOURCING MODEL, 2018-2030 (USD MILLION)
TABLE 67. AMERICAS BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 68. UNITED STATES BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 69. UNITED STATES BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY CLINICAL RESEARCH, 2018-2030 (USD MILLION)
TABLE 70. UNITED STATES BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY CONTRACT MANUFACTURING, 2018-2030 (USD MILLION)
TABLE 71. UNITED STATES BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY LABORATORY SERVICES, 2018-2030 (USD MILLION)
TABLE 72. UNITED STATES BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY PHARMACOVIGILANCE, 2018-2030 (USD MILLION)
TABLE 73. UNITED STATES BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY PRECLINICAL RESEARCH, 2018-2030 (USD MILLION)
TABLE 74. UNITED STATES BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY REGULATORY AFFAIRS, 2018-2030 (USD MILLION)
TABLE 75. UNITED STATES BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 76. UNITED STATES BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 77. UNITED STATES BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY OUTSOURCING MODEL, 2018-2030 (USD MILLION)
TABLE 78. UNITED STATES BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 79. CANADA BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 80. CANADA BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY CLINICAL RESEARCH, 2018-2030 (USD MILLION)
TABLE 81. CANADA BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY CONTRACT MANUFACTURING, 2018-2030 (USD MILLION)
TABLE 82. CANADA BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY LABORATORY SERVICES, 2018-2030 (USD MILLION)
TABLE 83. CANADA BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY PHARMACOVIGILANCE, 2018-2030 (USD MILLION)
TABLE 84. CANADA BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY PRECLINICAL RESEARCH, 2018-2030 (USD MILLION)
TABLE 85. CANADA BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY REGULATORY AFFAIRS, 2018-2030 (USD MILLION)
TABLE 86. CANADA BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 87. CANADA BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 88. CANADA BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY OUTSOURCING MODEL, 2018-2030 (USD MILLION)
TABLE 89. MEXICO BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 90. MEXICO BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY CLINICAL RESEARCH, 2018-2030 (USD MILLION)
TABLE 91. MEXICO BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY CONTRACT MANUFACTURING, 2018-2030 (USD MILLION)
TABLE 92. MEXICO BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY LABORATORY SERVICES, 2018-2030 (USD MILLION)
TABLE 93. MEXICO BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY PHARMACOVIGILANCE, 2018-2030 (USD MILLION)
TABLE 94. MEXICO BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY PRECLINICAL RESEARCH, 2018-2030 (USD MILLION)
TABLE 95. MEXICO BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY REGULATORY AFFAIRS, 2018-2030 (USD MILLION)
TABLE 96. MEXICO BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 97. MEXICO BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 98. MEXICO BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY OUTSOURCING MODEL, 2018-2030 (USD MILLION)
TABLE 99. BRAZIL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 100. BRAZIL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY CLINICAL RESEARCH, 2018-2030 (USD MILLION)
TABLE 101. BRAZIL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY CONTRACT MANUFACTURING, 2018-2030 (USD MILLION)
TABLE 102. BRAZIL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY LABORATORY SERVICES, 2018-2030 (USD MILLION)
TABLE 103. BRAZIL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY PHARMACOVIGILANCE, 2018-2030 (USD MILLION)
TABLE 104. BRAZIL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY PRECLINICAL RESEARCH, 2018-2030 (USD MILLION)
TABLE 105. BRAZIL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY REGULATORY AFFAIRS, 2018-2030 (USD MILLION)
TABLE 106. BRAZIL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 107. BRAZIL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 108. BRAZIL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY OUTSOURCING MODEL, 2018-2030 (USD MILLION)
TABLE 109. ARGENTINA BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 110. ARGENTINA BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY CLINICAL RESEARCH, 2018-2030 (USD MILLION)
TABLE 111. ARGENTINA BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY CONTRACT MANUFACTURING, 2018-2030 (USD MILLION)
TABLE 112. ARGENTINA BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY LABORATORY SERVICES, 2018-2030 (USD MILLION)
TABLE 113. ARGENTINA BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY PHARMACOVIGILANCE, 2018-2030 (USD MILLION)
TABLE 114. ARGENTINA BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY PRECLINICAL RESEARCH, 2018-2030 (USD MILLION)
TABLE 115. ARGENTINA BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY REGULATORY AFFAIRS, 2018-2030 (USD MILLION)
TABLE 116. ARGENTINA BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 117. ARGENTINA BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 118. ARGENTINA BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY OUTSOURCING MODEL, 2018-2030 (USD MILLION)
TABLE 119. EUROPE, MIDDLE EAST & AFRICA BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 120. EUROPE, MIDDLE EAST & AFRICA BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY CLINICAL RESEARCH, 2018-2030 (USD MILLION)
TABLE 121. EUROPE, MIDDLE EAST & AFRICA BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY CONTRACT MANUFACTURING, 2018-2030 (USD MILLION)
TABLE 122. EUROPE, MIDDLE EAST & AFRICA BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY LABORATORY SERVICES, 2018-2030 (USD MILLION)
TABLE 123. EUROPE, MIDDLE EAST & AFRICA BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY PHARMACOVIGILANCE, 2018-2030 (USD MILLION)
TABLE 124. EUROPE, MIDDLE EAST & AFRICA BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY PRECLINICAL RESEARCH, 2018-2030 (USD MILLION)
TABLE 125. EUROPE, MIDDLE EAST & AFRICA BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY REGULATORY AFFAIRS, 2018-2030 (USD MILLION)
TABLE 126. EUROPE, MIDDLE EAST & AFRICA BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 127. EUROPE, MIDDLE EAST & AFRICA BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 128. EUROPE, MIDDLE EAST & AFRICA BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY OUTSOURCING MODEL, 2018-2030 (USD MILLION)
TABLE 129. EUROPE, MIDDLE EAST & AFRICA BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 130. UNITED KINGDOM BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 131. UNITED KINGDOM BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY CLINICAL RESEARCH, 2018-2030 (USD MILLION)
TABLE 132. UNITED KINGDOM BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY CONTRACT MANUFACTURING, 2018-2030 (USD MILLION)
TABLE 133. UNITED KINGDOM BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY LABORATORY SERVICES, 2018-2030 (USD MILLION)
TABLE 134. UNITED KINGDOM BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY PHARMACOVIGILANCE, 2018-2030 (USD MILLION)
TABLE 135. UNITED KINGDOM BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY PRECLINICAL RESEARCH, 2018-2030 (USD MILLION)
TABLE 136. UNITED KINGDOM BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY REGULATORY AFFAIRS, 2018-2030 (USD MILLION)
TABLE 137. UNITED KINGDOM BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 138. UNITED KINGDOM BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 139. UNITED KINGDOM BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY OUTSOURCING MODEL, 2018-2030 (USD MILLION)
TABLE 140. GERMANY BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 141. GERMANY BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY CLINICAL RESEARCH, 2018-2030 (USD MILLION)
TABLE 142. GERMANY BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY CONTRACT MANUFACTURING, 2018-2030 (USD MILLION)
TABLE 143. GERMANY BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY LABORATORY SERVICES, 2018-2030 (USD MILLION)
TABLE 144. GERMANY BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY PHARMACOVIGILANCE, 2018-2030 (USD MILLION)
TABLE 145. GERMANY BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY PRECLINICAL RESEARCH, 2018-2030 (USD MILLION)
TABLE 146. GERMANY BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY REGULATORY AFFAIRS, 2018-2030 (USD MILLION)
TABLE 147. GERMANY BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 148. GERMANY BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 149. GERMANY BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY OUTSOURCING MODEL, 2018-2030 (USD MILLION)
TABLE 150. FRANCE BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 151. FRANCE BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY CLINICAL RESEARCH, 2018-2030 (USD MILLION)
TABLE 152. FRANCE BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY CONTRACT MANUFACTURING, 2018-2030 (USD MILLION)
TABLE 153. FRANCE BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY LABORATORY SERVICES, 2018-2030 (USD MILLION)
TABLE 154. FRANCE BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY PHARMACOVIGILANCE, 2018-2030 (USD MILLION)
TABLE 155. FRANCE BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY PRECLINICAL RESEARCH, 2018-2030 (USD MILLION)
TABLE 156. FRANCE BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY REGULATORY AFFAIRS, 2018-2030 (USD MILLION)
TABLE 157. FRANCE BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 158. FRANCE BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 159. FRANCE BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY OUTSOURCING MODEL, 2018-2030 (USD MILLION)
TABLE 160. RUSSIA BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 161. RUSSIA BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY CLINICAL RESEARCH, 2018-2030 (USD MILLION)
TABLE 162. RUSSIA BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY CONTRACT MANUFACTURING, 2018-2030 (USD MILLION)
TABLE 163. RUSSIA BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY LABORATORY SERVICES, 2018-2030 (USD MILLION)
TABLE 164. RUSSIA BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY PHARMACOVIGILANCE, 2018-2030 (USD MILLION)
TABLE 165. RUSSIA BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY PRECLINICAL RESEARCH, 2018-2030 (USD MILLION)
TABLE 166. RUSSIA BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY REGULATORY AFFAIRS, 2018-2030 (USD MILLION)
TABLE 167. RUSSIA BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 168. RUSSIA BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 169. RUSSIA BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY OUTSOURCING MODEL, 2018-2030 (USD MILLION)
TABLE 170. ITALY BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 171. ITALY BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY CLINICAL RESEARCH, 2018-2030 (USD MILLION)
TABLE 172. ITALY BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY CONTRACT MANUFACTURING, 2018-2030 (USD MILLION)
TABLE 173. ITALY BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY LABORATORY SERVICES, 2018-2030 (USD MILLION)
TABLE 174. ITALY BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY PHARMACOVIGILANCE, 2018-2030 (USD MILLION)
TABLE 175. ITALY BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY PRECLINICAL RESEARCH, 2018-2030 (USD MILLION)
TABLE 176. ITALY BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY REGULATORY AFFAIRS, 2018-2030 (USD MILLION)
TABLE 177. ITALY BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 178. ITALY BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 179. ITALY BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY OUTSOURCING MODEL, 2018-2030 (USD MILLION)
TABLE 180. SPAIN BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 181. SPAIN BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY CLINICAL RESEARCH, 2018-2030 (USD MILLION)
TABLE 182. SPAIN BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY CONTRACT MANUFACTURING, 2018-2030 (USD MILLION)
TABLE 183. SPAIN BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY LABORATORY SERVICES, 2018-2030 (USD MILLION)
TABLE 184. SPAIN BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY PHARMACOVIGILANCE, 2018-2030 (USD MILLION)
TABLE 185. SPAIN BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY PRECLINICAL RESEARCH, 2018-2030 (USD MILLION)
TABLE 186. SPAIN BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY REGULATORY AFFAIRS, 2018-2030 (USD MILLION)
TABLE 187. SPAIN BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 188. SPAIN BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 189. SPAIN BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY OUTSOURCING MODEL, 2018-2030 (USD MILLION)
TABLE 190. UNITED ARAB EMIRATES BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 191. UNITED ARAB EMIRATES BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY CLINICAL RESEARCH, 2018-2030 (USD MILLION)
TABLE 192. UNITED ARAB EMIRATES BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY CONTRACT MANUFACTURING, 2018-2030 (USD MILLION)
TABLE 193. UNITED ARAB EMIRATES BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY LABORATORY SERVICES, 2018-2030 (USD MILLION)
TABLE 194. UNITED ARAB EMIRATES BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY PHARMACOVIGILANCE, 2018-2030 (USD MILLION)
TABLE 195. UNITED ARAB EMIRATES BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY PRECLINICAL RESEARCH, 2018-2030 (USD MILLION)
TABLE 196. UNITED ARAB EMIRATES BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY REGULATORY AFFAIRS, 2018-2030 (USD MILLION)
TABLE 197. UNITED ARAB EMIRATES BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 198. UNITED ARAB EMIRATES BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 199. UNITED ARAB EMIRATES BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY OUTSOURCING MODEL, 2018-2030 (USD MILLION)
TABLE 200. SAUDI ARABIA BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 201. SAUDI ARABIA BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY CLINICAL RESEARCH, 2018-2030 (USD MILLION)
TABLE 202. SAUDI ARABIA BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY CONTRACT MANUFACTURING, 2018-2030 (USD MILLION)
TABLE 203. SAUDI ARABIA BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY LABORATORY SERVICES, 2018-2030 (USD MILLION)
TABLE 204. SAUDI ARABIA BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY PHARMACOVIGILANCE, 2018-2030 (USD MILLION)
TABLE 205. SAUDI ARABIA BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY PRECLINICAL RESEARCH, 2018-2030 (USD MILLION)
TABLE 206. SAUDI ARABIA BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY REGULATORY AFFAIRS, 2018-2030 (USD MILLION)
TABLE 207. SAUDI ARABIA BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 208. SAUDI ARABIA BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 209. SAUDI ARABIA BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY OUTSOURCING MODEL, 2018-2030 (USD MILLION)
TABLE 210. SOUTH AFRICA BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 211. SOUTH AFRICA BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY CLINICAL RESEARCH, 2018-2030 (USD MILLION)
TABLE 212. SOUTH AFRICA BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY CONTRACT MANUFACTURING, 2018-2030 (USD MILLION)
TABLE 213. SOUTH AFRICA BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY LABORATORY SERVICES, 2018-2030 (USD MILLION)
TABLE 214. SOUTH AFRICA BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY PHARMACOVIGILANCE, 2018-2030 (USD MILLION)
TABLE 215. SOUTH AFRICA BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY PRECLINICAL RESEARCH, 2018-2030 (USD MILLION)
TABLE 216. SOUTH AFRICA BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY REGULATORY AFFAIRS, 2018-2030 (USD MILLION)
TABLE 217. SOUTH AFRICA BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 218. SOUTH AFRICA BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 219. SOUTH AFRICA BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY OUTSOURCING MODEL, 2018-2030 (USD MILLION)
TABLE 220. DENMARK BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 221. DENMARK BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY CLINICAL RESEARCH, 2018-2030 (USD MILLION)
TABLE 222. DENMARK BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY CONTRACT MANUFACTURING, 2018-2030 (USD MILLION)
TABLE 223. DENMARK BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY LABORATORY SERVICES, 2018-2030 (USD MILLION)
TABLE 224. DENMARK BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY PHARMACOVIGILANCE, 2018-2030 (USD MILLION)
TABLE 225. DENMARK BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY PRECLINICAL RESEARCH, 2018-2030 (USD MILLION)
TABLE 226. DENMARK BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY REGULATORY AFFAIRS, 2018-2030 (USD MILLION)
TABLE 227. DENMARK BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 228. DENMARK BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 229. DENMARK BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY OUTSOURCING MODEL, 2018-2030 (USD MILLION)
TABLE 230. NETHERLANDS BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 231. NETHERLANDS BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY CLINICAL RESEARCH, 2018-2030 (USD MILLION)
TABLE 232. NETHERLANDS BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY CONTRACT MANUFACTURING, 2018-2030 (USD MILLION)
TABLE 233. NETHERLANDS BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY LABORATORY SERVICES, 2018-2030 (USD MILLION)
TABLE 234. NETHERLANDS BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY PHARMACOVIGILANCE, 2018-2030 (USD MILLION)
TABLE 235. NETHERLANDS BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY PRECLINICAL RESEARCH, 2018-2030 (USD MILLION)
TABLE 236. NETHERLANDS BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY REGULATORY AFFAIRS, 2018-2030 (USD MILLION)
TABLE 237. NETHERLANDS BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 238. NETHERLANDS BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 239. NETHERLANDS BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY OUTSOURCING MODEL, 2018-2030 (USD MILLION)
TABLE 240. QATAR BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 241. QATAR BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY CLINICAL RESEARCH, 2018-2030 (USD MILLION)
TABLE 242. QATAR BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY CONTRACT MANUFACTURING, 2018-2030 (USD MILLION)
TABLE 243. QATAR BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY LABORATORY SERVICES, 2018-2030 (USD MILLION)
TABLE 244. QATAR BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY PHARMACOVIGILANCE, 2018-2030 (USD MILLION)
TABLE 245. QATAR BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY PRECLINICAL RESEARCH, 2018-2030 (USD MILLION)
TABLE 246. QATAR BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY REGULATORY AFFAIRS, 2018-2030 (USD MILLION)
TABLE 247. QATAR BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 248. Q

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Biotechnology & Pharmaceutical Services Outsourcing market report include:
  • IQVIA Holdings Inc.
  • Laboratory Corporation of America Holdings
  • Thermo Fisher Scientific Inc.
  • Syneos Health, Inc.
  • Parexel International Corporation
  • ICON plc
  • Charles River Laboratories International, Inc.
  • WuXi AppTec Co., Ltd.
  • Catalent, Inc.
  • Medpace Holdings, Inc.

Table Information

Report AttributeDetails
No. of Pages196
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 188.18 Billion
Forecasted Market Value ( USD ) by 2030 $ 330.57 Billion
Compound Annual Growth Rate11.9%
Regions CoveredGlobal
No. of Companies Mentioned10

Related Topics

Related Reports

Pharmaceutical Services Outsourcing Market by Service Type, Clinical Phase, Customer Type, Contract Model, Therapeutic Area - Global Forecast to 2030 - Product Image

Pharmaceutical Services Outsourcing Market by Service Type, Clinical Phase, Customer Type, Contract Model, Therapeutic Area - Global Forecast to 2030

  • Report
  • 181 Pages
  • Global
From
Biotechnology / Pharmaceutical Services Outsourcing - Global Strategic Business Report - Product Image

Biotechnology / Pharmaceutical Services Outsourcing - Global Strategic Business Report

  • Report
  • 196 Pages
  • Global
From
Chemistry, Manufacturing And Control Services Outsourcing Market Size, Share & Trends Analysis Report By Type, By Service, By End-use, By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Chemistry, Manufacturing And Control Services Outsourcing Market Size, Share & Trends Analysis Report By Type, By Service, By End-use, By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 150 Pages
  • Global
From
North America Biotechnology And Pharmaceutical Services Outsourcing Market Size, Share & Trends Analysis Report By Service (Consulting, Regulatory Affairs), By End Use, By Country, And Segment Forecasts, 2024 - 2030 - Product Image

North America Biotechnology And Pharmaceutical Services Outsourcing Market Size, Share & Trends Analysis Report By Service (Consulting, Regulatory Affairs), By End Use, By Country, And Segment Forecasts, 2024 - 2030

  • Report
  • 110 Pages
  • North America
From
Life Sciences BPO Market by Service Type, End User, Outsourcing Model, Organization Size - Global Forecast to 2030 - Product Image

Life Sciences BPO Market by Service Type, End User, Outsourcing Model, Organization Size - Global Forecast to 2030

  • Report
  • 196 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.